Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download

  Prostate Cancer

  Free Subscription

Articles published in Radiology

Retrieve available abstracts of 54 articles:
HTML format

Single Articles

    July 2020
    Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI in Biochemically Recurrent Prostate Cancer.
    Radiology. 2020 Jul 7:202098. doi: 10.1148/radiol.2020202098.

  2. LINDENBERG L, Mena E, Turkbey B, Shih JH, et al
    Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI.
    Radiology. 2020 Jul 7:192018. doi: 10.1148/radiol.2020192018.
    PubMed     Abstract available

    June 2020
  3. ZHANG Z, Wu HH, Priester A, Magyar C, et al
    Prostate Microstructure in Prostate Cancer Using 3-T MRI with Diffusion-Relaxation Correlation Spectrum Imaging: Validation with Whole-Mount Digital Histopathology.
    Radiology. 2020 Jun 9:192330. doi: 10.1148/radiol.2020192330.
    PubMed     Abstract available

    May 2020
  4. TAN N, Oyoyo U, Bavadian N, Ferguson N, et al
    PSMA-targeted Radiotracers versus (18)F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.
    Radiology. 2020 May 12:191689. doi: 10.1148/radiol.2020191689.
    PubMed     Abstract available

  5. PADHANI AR, Petralia G
    Radiologists Should Integrate Clinical Risk Factors with MRI Findings for Meaningful Prostate Cancer Staging.
    Radiology. 2020 May 5:201082. doi: 10.1148/radiol.2020201082.

    April 2020
  6. WESTPHALEN AC, McCulloch CE, Anaokar JM, Arora S, et al
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
    Radiology. 2020 Apr 21:190646. doi: 10.1148/radiol.2020190646.
    PubMed     Abstract available

  7. MEYRIGNAC O, Aziza R, Roumiguie M, Malavaud B, et al
    Closing the Gap between Prostate Cancer and Deep Learning Detection Tools.
    Radiology. 2020 Apr 14:200187. doi: 10.1148/radiol.2020200187.

    October 2019
  8. PADHANI AR, Turkbey B
    Detecting Prostate Cancer with Deep Learning for MRI: A Small Step Forward.
    Radiology. 2019 Oct 8:192012. doi: 10.1148/radiol.2019192012.

  9. SCHELB P, Kohl S, Radtke JP, Wiesenfarth M, et al
    Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment.
    Radiology. 2019 Oct 8:190938. doi: 10.1148/radiol.2019190938.
    PubMed     Abstract available

    September 2019
  10. MUEHLEMATTER UJ, Burger IA, Becker AS, Schawkat K, et al
    Diagnostic Accuracy of Multiparametric MRI versus (68)Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer.
    Radiology. 2019 Sep 10:190687. doi: 10.1148/radiol.2019190687.
    PubMed     Abstract available

  11. PANDA A, Obmann VC, Lo WC, Margevicius S, et al
    MR Fingerprinting and ADC Mapping for Characterization of Lesions in the Transition Zone of the Prostate Gland.
    Radiology. 2019;292:685-694.
    PubMed     Abstract available

    June 2019
  12. PEREZ-LOPEZ R, Tunariu N, Padhani AR, Oyen WJG, et al
    Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.
    Radiology. 2019 Jun 25:181931. doi: 10.1148/radiol.2019181931.
    PubMed     Abstract available

  13. PADHANI AR, Barentsz J, Villeirs G, Rosenkrantz AB, et al
    PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.
    Radiology. 2019 Jun 11:182946. doi: 10.1148/radiol.2019182946.
    PubMed     Abstract available

  14. COLLETTINI F, Enders J, Stephan C, Fischer T, et al
    Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes.
    Radiology. 2019 Jun 4:181987. doi: 10.1148/radiol.2019181987.
    PubMed     Abstract available

    April 2019
  15. SIGMUND EE, Rosenkrantz AB
    Diffusion-weighted Imaging of Prostate Cancer: Revisiting Occam's Razor.
    Radiology. 2019 Apr 2:190371. doi: 10.1148/radiol.2019190371.

  16. JOHNSTON EW, Bonet-Carne E, Ferizi U, Yvernault B, et al
    VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.
    Radiology. 2019 Apr 2:181749. doi: 10.1148/radiol.2019181749.
    PubMed     Abstract available

    March 2019
  17. SCIALPI M, Bianconi F, Cantisani V, Palumbo B, et al
    Radiomic Machine Learning: Is It Really a Useful Method for the Characterization of Prostate Cancer?
    Radiology. 2019 Mar 5:182940. doi: 10.1148/radiol.2019182940.

    January 2019
  18. ZHANG M, Milot L, Khalvati F, Sugar L, et al
    Value of Increasing Biopsy Cores per Target with Cognitive MRI-targeted Transrectal US Prostate Biopsy.
    Radiology. 2019 Jan 29:180712. doi: 10.1148/radiol.2019180712.
    PubMed     Abstract available

  19. MEHRALIVAND S, Shih JH, Harmon S, Smith C, et al
    A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
    Radiology. 2019 Jan 22:181278. doi: 10.1148/radiol.2018181278.
    PubMed     Abstract available

    Local Staging of Prostate Cancer with MRI: A Need for Standardization.
    Radiology. 2019 Jan 22:182943. doi: 10.1148/radiol.2019182943.

  21. WINKEL DJ, Heye TJ, Benz MR, Glessgen CG, et al
    Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer.
    Radiology. 2019 Jan 1:180556. doi: 10.1148/radiol.2018180556.
    PubMed     Abstract available

    November 2018
  22. SCIALPI M, Scialpi P, Aisa MC, Martorana E, et al
    Simplified PI-RADS with Biparametric MRI: A Practical Approach to Improve Management of PI-RADS Version 2 Category 3 Lesions.
    Radiology. 2018 Nov 6:182092. doi: 10.1148/radiol.2018182092.

    September 2018
  23. HICKS RM, Simko JP, Westphalen AC, Nguyen HG, et al
    Diagnostic Accuracy of (68)Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer.
    Radiology. 2018 Sep 18:180788. doi: 10.1148/radiol.2018180788.
    PubMed     Abstract available

    (68)Ga-PSMA-11 PET: Better at Detecting Prostate Cancer than Multiparametric MRI?
    Radiology. 2018 Sep 18:181981. doi: 10.1148/radiol.2018181981.

    August 2018
    Organized Chaos: Does PI-RADS Version 2 Work in the Transition Zone?
    Radiology. 2018;288:492-494.

    July 2018
  26. BONEKAMP D, Kohl S, Wiesenfarth M, Schelb P, et al
    Radiomic Machine Learning for Characterization of Prostate Lesions with MRI: Comparison to ADC Values.
    Radiology. 2018 Jul 31:173064. doi: 10.1148/radiol.2018173064.
    PubMed     Abstract available

  27. SHANKAR PR, Kaza RK, Al-Hawary MM, Masch WR, et al
    Impact of Clinical History on Maximum PI-RADS Version 2 Score: A Six-Reader 120-Case Sham History Retrospective Evaluation.
    Radiology. 2018;288:158-163.
    PubMed     Abstract available

    June 2018
  28. STANZIONE A, Cocozza S, Cuocolo R, Imbriaco M, et al
    Biparametric Prostate MR Imaging Protocol: Time to Revise PI-RADS Version 2?
    Radiology. 2018;287:1082.

    May 2018
  29. THAI JN, Narayanan HA, George AK, Siddiqui MM, et al
    Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer.
    Radiology. 2018 May 18:170425. doi: 10.1148/radiol.2018170425.
    PubMed     Abstract available

  30. PARK SY, Zacharias C, Harrison C, Fan RE, et al
    Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer.
    Radiology. 2018 May 16:172232. doi: 10.1148/radiol.2018172232.
    PubMed     Abstract available

  31. LOPCI E, Guazzoni G, Lazzeri M
    (68)Ga Prostate-specific Membrane Antigen PET/CT for Primary Diagnosis of Prostate Cancer: Complementary or Alternative to Multiparametric MR Imaging.
    Radiology. 2018;287:725-726.

    April 2018
    Prostate Cancer: Improving the Flow of Research.
    Radiology. 2018;287:5-9.
    PubMed     Abstract available

    March 2018
  33. UENO Y, Tamada T, Takahashi S
    Detection of Clinically Significant Prostate Cancer by Using Abbreviated Biparametric Prostate MR Imaging.
    Radiology. 2018;286:1093-1094.

    February 2018
  34. CHATTERJEE A, Bourne RM, Wang S, Devaraj A, et al
    Diagnosis of Prostate Cancer with Noninvasive Estimation of Prostate Tissue Composition by Using Hybrid Multidimensional MR Imaging: A Feasibility Study.
    Radiology. 2018 Feb 2:171130. doi: 10.1148/radiol.2018171130.
    PubMed     Abstract available

  35. KAJI Y, Inamura K
    Diagnostic Ability with Abbreviated Biparametric and Full Multiparametric Prostate MR Imaging: Is the Use of PI-RADS Version 2 Appropriate for Comparison?
    Radiology. 2018;286:726-727.

    January 2018
  36. DINH AH, Melodelima C, Souchon R, Moldovan PC, et al
    Characterization of Prostate Cancer with Gleason Score of at Least 7 by Using Quantitative Multiparametric MR Imaging: Validation of a Computer-aided Diagnosis System in Patients Referred for Prostate Biopsy.
    Radiology. 2018 Jan 22:171265. doi: 10.1148/radiol.2017171265.
    PubMed     Abstract available

  37. CORNUD F, Roumiguie M, Barry de Longchamps N, Ploussard G, et al
    Precision Matters in MR Imaging-targeted Prostate Biopsies: Evidence from a Prospective Study of Cognitive and Elastic Fusion Registration Transrectal Biopsies.
    Radiology. 2018 Jan 22:162916. doi: 10.1148/radiol.2017162916.
    PubMed     Abstract available

  38. SCIALPI M, Martorana E, Aisa MC, Rondoni V, et al
    Abbreviated Biparametric Prostate MR Imaging: Is It Really an Alternative to Multiparametric MR Imaging?
    Radiology. 2018;286:360-361.

    December 2017
  39. TEMIZ MZ
    MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men.
    Radiology. 2017;285:1052-1053.

  40. THOENY HC, Barbieri S, Froehlich JM, Turkbey B, et al
    Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges.
    Radiology. 2017;285:728-743.
    PubMed     Abstract available

    November 2017
  41. HECTORS SJ, Semaan S, Song C, Lewis S, et al
    Advanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition-A Hypothesis-generating Study.
    Radiology. 2017 Nov 8:170904. doi: 10.1148/radiol.2017170904.
    PubMed     Abstract available

  42. VERMA S, Choyke PL, Eberhardt SC, Oto A, et al
    The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.
    Radiology. 2017;285:343-356.
    PubMed     Abstract available

    October 2017
  43. BOROFSKY S, George AK, Gaur S, Bernardo M, et al
    What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.
    Radiology. 2017 Oct 20:152877. doi: 10.1148/radiol.2017152877.
    PubMed     Abstract available

    July 2017
  44. KUHL CK, Bruhn R, Kramer N, Nebelung S, et al
    Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.
    Radiology. 2017 Jul 20:170129. doi: 10.1148/radiol.2017170129.
    PubMed     Abstract available

  45. GREER MD, Shih JH, Lay N, Barrett T, et al
    Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.
    Radiology. 2017 Jul 19:161316. doi: 10.1148/radiol.2017161316.
    PubMed     Abstract available

    June 2017
  46. TAY KJ, Cheng CWS, Lau WKO, Khoo J, et al
    Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
    Radiology. 2017 Jun 26:161650. doi: 10.1148/radiol.2017161650.
    PubMed     Abstract available

  47. KWAK JT, Sankineni S, Xu S, Turkbey B, et al
    Prostate Cancer: A Correlative Study of Multiparametric MR Imaging and Digital Histopathology.
    Radiology. 2017 Jun 5:160906. doi: 10.1148/radiol.2017160906.
    PubMed     Abstract available

    May 2017
  48. PAHWA S, Schiltz NK, Ponsky LE, Lu Z, et al
    Cost-effectiveness of MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men.
    Radiology. 2017 May 17:162181. doi: 10.1148/radiol.2017162181.
    PubMed     Abstract available

    April 2017
  49. JAMSHIDI N, Margolis DJ, Raman S, Huang J, et al
    Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma.
    Radiology. 2017 Apr 28:162827. doi: 10.1148/radiol.2017162827.
    PubMed     Abstract available

  50. TAMADA T, Prabhu V, Li J, Babb JS, et al
    Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models.
    Radiology. 2017 Apr 10:162321. doi: 10.1148/radiol.2017162321.
    PubMed     Abstract available

  51. SABOURI S, Chang SD, Savdie R, Zhang J, et al
    Luminal Water Imaging: A New MR Imaging T2 Mapping Technique for Prostate Cancer Diagnosis.
    Radiology. 2017 Apr 10:161687. doi: 10.1148/radiol.2017161687.
    PubMed     Abstract available

    March 2017
  52. BARTH BK, De Visschere PJ, Cornelius A, Nicolau C, et al
    Detection of Clinically Significant Prostate Cancer: Short Dual-Pulse Sequence versus Standard Multiparametric MR Imaging-A Multireader Study.
    Radiology. 2017 Mar 27:162020. doi: 10.1148/radiol.2017162020.
    PubMed     Abstract available

    November 2016
  53. CHEVILLET JR, Khokhlova TD, Giraldez MD, Schade GR, et al
    Release of Cell-free MicroRNA Tumor Biomarkers into the Blood Circulation with Pulsed Focused Ultrasound: A Noninvasive, Anatomically Localized, Molecular Liquid Biopsy.
    Radiology. 2016 Nov 1:160024.
    PubMed     Abstract available

  54. JOHNSTON E, Punwani S
    Can We Improve the Reproducibility of Quantitative Multiparametric Prostate MR Imaging Metrics?
    Radiology. 2016;281:652-653.

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.